Marketplace

The first Marketplace for patents, utility models and novel technologies.


  • Get increased visibility for novel products.

  • Test potential demand and novel markets.

Contact us

Mechanism of Action and NRF2 Target Engagement
Demonstrate the robust, specific activation of NRF2 by candidate compounds. ARE-luciferase assays (EC50/IC50). KEAP1/NRF2 protein-protein interaction assays (FP/AlphaScreen). NRF2-dependent gene and protein expression profiling. Promoter occupancy confirmation (TransAM, ChIP-qPCR/ChIP-seq)

*Contact us for details
0.00 € 0.0 EUR
In Silico Redox Selectivity and Preliminary Safety
Early de-risking to flag promiscuous compounds and off-target liabilities. ADME/DMPK predictions (permeability, stability, PPB, clearance) AI-based toxicity alerts (hERG, CYP TDI, mitochondrial toxicity, etc.) Compound scoring and go/no-go recommendations.

*Contact us for details
0.00 € 0.0 EUR
Cytoprotection under Oxidative Stress (In Vitro PoC)
Functional proof-of-concept across human and rodent cell systems. Oxidative stress challenges (t-BHP/H₂O₂) in hepatocytes, SH-SY5Y neurons, retinal and cardiac cells. Readouts: viability, ROS, apoptosis via flow cytometry and confocal microscopy. Pharmacodynamics: NRF2-dependent genes and proteins (HMOX1, NQO1).

*Contact us for details
0.00 € 0.0 EUR
Accelerated Proof of Concept for MASH/NASH (12–16 weeks)
Translational in vivo efficacy integrating NRF2 pharmacodynamic biomarkers. Endpoints: NAS (steatosis, inflammation, ballooning), fibrosis, ALT/AST, lipids, hepatic NRF2 biomarkers. Animal models: STAM and choline-deficient variants (in collaboration with IIB “Sols-Morreale” CSIC-UAM). Imaging: MRI for non-invasive hepatic/adipose metabolism assessment.

*Contact us for details
0.00 € 0.0 EUR
Proof of Concept in Neurodegeneration (Alzheimer’s & Parkinson’s)
Evaluate NRF2 contribution in translational neurodegenerative models. Alzheimer’s: APP/TAU ± NRF2 models; pathology, neuroinflammation, and behavior. Parkinson’s: MPTP and α-synuclein models; motor and nigrostriatal biomarkers. CNS-NRF2 panel: integration of oxidative stress and inflammasome markers.

*Contact us for details
0.00 € 0.0 EUR
Systemic Inflammation and Inflammasome Analytics
Characterize NRF2 modulation across inflammatory processes. In vitro & in vivo LPS activation in cells and mice; cytokine profiling. Key biomarkers: caspase-1, IL-1β, IL-18; tissue-level NRF2 pharmacodynamics. Deliverables: integrated cytokine profiles, mechanistic links to NRF2 activity.

*Contact us for details
0.00 € 0.0 EUR

Willing to upload your product?

Please, send us:

  1. Title and brief description of your product.
  2. Representative photograph.
  3. Price (excluding VAT).

That is all, your product will be ready and available in our marketplace!

Please check our General Terms and Conditions for online purchases.

Frequently Asked Questions about Marketplace

Where can I find verified scientific technologies or sell my university's patents to global buyers?

KnowTransfer operates as a specialized Sci-Tech Marketplace that bridges the gap between labs and corporations:

  • Global Visibility: We list your technology in a global database accessed by specialized investors and industrial scouts.
  • Verified Portfolio: Every technology in our marketplace has undergone a preliminary valuation and technology Readiness Level (TRL) check.
  • Direct Connections: We facilitate direct communication between technology owners and potential licensees or buyers.

KnowTransfer's advice: A patent is a dormant asset if it's not visible. Use a specialized marketplace to increase the chances of technology licensing.

Ready to value your tech? Contact us.